Cempra Inc (NASDAQ:CEMP) shares are rising close to 6% today on back of the biotech firm’s reveal that Phase 3 data read-outs in …
Global Blood Therapeutics Inc (NASDAQ:GBT) shares rose about 9% today after the biopharmaceutical company initiated a Phase 1 trial evaluating GBT440 in healthy volunteers under hypoxic …
Zosano Pharma Corp (NASDAQ:ZSAN) shares skyrocketed over 170% in the past three days, after the company reported positive pivotal trial data for its M207 migraine …
NVIDIA Corporation (NASDAQ:NVDA) is on course to deliver outstanding earnings this coming Thursday, according to Roth Capital analyst Brian Alger. The analyst points out that his meetings …
As a sign of confidence in Glu Mobile Inc. (NASDAQ:GLUU), Roth Capital analyst Darren Aftahi is upgrading the stock from Neutral to Buy, while …
xG Technology Inc (NASDAQ:XGTI) shares are rising 4% on back of Roth Capital analyst William Gibson‘s new bullish stance on the tech firm. …
Roth Capital’s top analyst Brian Alger is out this morning with a new research note on Super Micro Computer, Inc. (NASDAQ:SMCI), after the high-end server maker posted …
Roth Capital analyst John M. White reiterated a Buy rating on shares of Halcon Resources Corporation (NYSE:HK) with a price target of $14, …
Roth Capital analyst Michael Higgins was out pounding the table on shares of Palatin Technologies, Inc. (NYSEMKT:PTN) Tuesday, resuming coverage with a Buy rating and a …
Late last week, Synergy Pharmaceuticals Inc (NASDAQ:SGYP) announced the FDA approval of its lead drug Trulance (plecanatide) for the treatment of adults with …